Stock, pipeline and biotech catalyst intelligence
Clinical portfolio
| Asset | Indication | Stage | Milestone | Signals ? |
|---|---|---|---|---|
| navenibart (STAR-0215) | Hereditary angioedema | Phase 3 | Mar 31, 2027 | Mgmt interest |
Upcoming milestones
Company profile
Astria Therapeutics is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
Hereditary angioedema